Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-16-121465

Chief Executive Officer bought 2,125 shares at $2.40 ($5,100)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-05-18 Purchase : show line 1 in the form +2,125 $2.40 $5,100 9,990 D
Open-market purchases · 2,125 sh · avg $2.40 · $5,100
Loading xslF345X03/doc4.xml…